Skin Cancer Awareness Month 2024 and Insights from Medicus Pharma
XTalks
MAY 23, 2024
Advances in genomic sequencing and molecular diagnostics are helping healthcare providers to identify specific mutations and biomarkers associated with skin cancer. is a biotech and life sciences company dedicated to advancing the clinical development of innovative and groundbreaking therapeutic assets.
Let's personalize your content